Elicio Therapeutics Inc. (ELTX)
NASDAQ: ELTX
· Real-Time Price · USD
11.78
1.94 (19.72%)
At close: Aug 18, 2025, 3:59 PM
11.85
0.64%
Pre-market: Aug 19, 2025, 07:00 AM EDT
Elicio Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 22.09M | 18.35M | 17.62M | 26.02M | 3.82M | 11.85M | 12.89M | 14.12M | 21.68M | 8.57M | 6.16M | 55.14M | 73M | 88.76M | 102.74M | 117.31M | 13.93M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.56M | n/a | n/a | n/a | n/a |
Long-Term Investments | 700K | 698K | 696K | 693K | 690K | 688K | 685K | 683K | 681K | n/a | 874K | 874K | 732K | 723K | 862K | 843K | n/a |
Other Long-Term Assets | 600K | 600K | 600K | 600K | 1.63M | 2.67M | 2.83M | 2.83M | 2.84M | 3.45M | 2.58M | 75K | 78K | 106K | 33K | 38K | 3.18M |
Receivables | n/a | n/a | n/a | 2K | 87K | n/a | n/a | 102K | 557K | n/a | n/a | 7K | 21K | 806K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -557K | n/a | 4.22M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 510K | 799K | 1.28M | 1.37M | 255K | 778K | 895K | 233K | 753K | 5.25M | 1.68M | 427K | 591K | 379K | 639K | 628K | 594.98K |
Total Current Assets | 22.6M | 20.93M | 20.69M | 30.65M | 6.69M | 14.13M | 16.35M | 19.93M | 26.23M | 13.82M | 10.72M | 56.68M | 76.24M | 91.25M | 104.39M | 119.7M | 15.01M |
Property-Plant & Equipment | 5.63M | 5.91M | 6.19M | 6.45M | 6.74M | 6.99M | 7.28M | 7.54M | 7.87M | 8.21M | 8.5M | 3.69M | 4.21M | 4.44M | 4.65M | 4.78M | 939.32K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 6.93M | 7.21M | 7.49M | 7.74M | 9.06M | 10.35M | 10.8M | 11.06M | 11.39M | 11.66M | 11.95M | 4.64M | 5.02M | 5.27M | 5.55M | 5.66M | 4.11M |
Total Assets | 29.53M | 28.14M | 28.18M | 38.39M | 15.75M | 24.48M | 27.15M | 30.99M | 37.62M | 25.48M | 22.66M | 61.32M | 81.26M | 96.51M | 109.94M | 125.36M | 19.12M |
Account Payables | 3.87M | 4.04M | 1.04M | 1.98M | 1.05M | 1.1M | 4.37M | 4.41M | 4.26M | 4.19M | 2.81M | 2.22M | 3.43M | 4.71M | 7.68M | 9.31M | 2.43M |
Deferred Revenue | n/a | n/a | 1.17M | n/a | n/a | 627K | 694K | 1.66M | 2.31M | n/a | n/a | n/a | 653K | 2.3M | 3.66M | 5.18M | n/a |
Short-Term Debt | n/a | 926K | 901K | 877K | 854K | 881K | 910K | 938K | n/a | 9.9M | n/a | 1.03M | 978K | 952K | 870K | 847K | n/a |
Other Current Liabilities | 3.83M | 452K | 1.41M | 1.9M | 3.71M | -141K | 975K | 701K | 149K | 3.54M | 2.93M | 23.52M | 5.32M | 3.33M | 5.74M | 1.1M | 590.73K |
Total Current Liabilities | 9.92M | 11.41M | 11.52M | 9.02M | 7.58M | 5.95M | 9.77M | 11.49M | 7.6M | 17.63M | 6.87M | 8.18M | 10.38M | 11.3M | 17.95M | 20.52M | 3.5M |
Long-Term Debt | 9.34M | n/a | 20.03M | 19.84M | n/a | n/a | n/a | n/a | n/a | 6.6M | n/a | 6.97M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 3.82M | 2.96M | 2.83M | 23.18M | 4.25M | 7.87M | n/a | n/a | 46K | 57.56K | 111.15M | -6.97M | 220K | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 17.77M | 7.83M | 27.97M | 48.35M | 9.82M | 13.66M | 6.01M | 6.21M | 6.46M | 6.66M | 117.94M | 2.92M | 3.67M | 3.71M | 27.48M | 27.65M | 70.49M |
Total Liabilities | 27.69M | 19.24M | 39.49M | 57.37M | 17.4M | 19.61M | 15.77M | 17.7M | 14.06M | 24.29M | 124.81M | 11.11M | 14.06M | 15.01M | 45.43M | 48.17M | 3.5M |
Total Debt | 14.9M | 5.79M | 26.04M | 26.05M | 6.42M | 6.67M | 6.92M | 7.15M | 7.4M | 16.5M | 7.48M | 3.96M | 4.43M | 4.66M | 4.58M | 847K | 323.05K |
Common Stock | 163K | 160K | 110K | 108K | 103K | 102K | 96K | 84K | 84K | 181.03K | 176.99K | 301K | 300K | 300K | 304K | 303K | 137.41K |
Retained Earnings | -215.87M | -205.31M | -194.1M | -180.1M | -161.26M | -154.03M | -142.2M | -133.25M | -122.6M | -115.04M | -107.01M | -247.5M | -229.38M | -215.13M | -230.03M | -214.32M | -58.59M |
Comprehensive Income | -70K | -144K | -175K | -202K | -238K | -270K | -197K | -25K | -2K | n/a | 86K | 302K | -199K | -103K | -73K | -219K | -210.44K |
Shareholders Equity | 1.83M | 8.9M | -11.31M | -18.99M | -1.65M | 4.87M | 11.37M | 13.29M | 23.56M | 1.18M | -102.15M | 50.21M | 67.2M | 81.51M | 64.51M | 77.19M | 15.57M |
Total Investments | 700K | 698K | 696K | 693K | 690K | 688K | 685K | 683K | 681K | n/a | 874K | 874K | 732K | 723K | 862K | 843K | n/a |